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As the intestinal microbiota has become better appreciated as necessary for
maintenance of physiologic homeostasis and also as a modulator of disease processes,
there has been a corresponding increase in manipulation of the microbiota in mouse
models. While germ-free mouse models are generally considered to be the gold standard
for studies of the microbiota, many investigators turn to antibiotics treatment models as
a rapid, inexpensive, and accessible alternative. Here we describe and compare these
two approaches, detailing advantages and disadvantages to both. Further, we detail
what is known about the effects of antibiotics treatment on cell populations, cytokines,
and organs, and clarify how this compares to germ-free models. Finally, we briefly
describe recent findings regarding microbiota regulation of infectious diseases and other
immunologic challenges by the microbiota, and highlight important future directions and
considerations for the use of antibiotics treatment in manipulation of the microbiota.
Keywords: antibiotics, microbiota, gnotobiotic, microbiome, immunity
INTRODUCTION
Over the past several decades, there has been a dramatic increase in both scientific and popular
interest in the effects of the intestinal microbiota on human health. The microbiota, consisting of
the bacteria, viruses, fungi, and archaea that inhabit different niches in the human body, has been
implicated in regulation of inflammatory, infectious and metabolic diseases, and appears to play
a critical role in potentially causing, propagating, or preventing human illnesses (Lai et al., 2014;
Norman et al., 2014; Palm et al., 2015). With the surge of enthusiasm to understand this new and
massively complex factor in human health has come the need to effectivelymodel it. Specifically, the
development of small animal models of the microbiota permits testing of subsets of the microbiota
as causative vs. correlative factors in disease states, as well as offering a system to uncover putative
therapeutics.
Two main methods have emerged to explore the effects of the microbiota on physiology and
disease in mice: germ-free models and antibiotics treatment regimens. Both approaches have
strengths and weaknesses. Here we will discuss commonly used regimens and methods to deplete
the microbiota, the effects of these approaches on host physiology including cellular composition,
signaling pathways, and organ function, and briefly describe what has been found using these two
different methods to model the effects of the microbiota on human disease.
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GERM-FREE AND ANTIBIOTICS
TREATMENT MODELS
Germ-free mice are bred in isolators which fully block exposure
to microorganisms, with the intent of keeping them free of
detectable bacteria, viruses, and eukaryotic microbes. Initially
conceptualized by Louis Pasteur in 1885, colonies of germ-
free rodents were first established in the 1940s (Yi and Li,
2012; Al-Asmakh and Zadjali, 2015). Germ-free mice allow
for study of the complete absence of microbes or for the
generation of gnotobiotic animals exclusively colonized by
known microbes. However, generating and maintaining these
mice requires specialized facilities, and the cost, labor, and
skills required to maintain them can make these models
inaccessible to many researchers. Germ-free mice must be
monitored regularly for contamination using a combination
of culturing, microscopy, serology, gross morphology, and
sequencing-based detection techniques (Fontaine et al., 2015;
Nicklas et al., 2015). For example, Charles River, one common
germ-free vendor, routinely uses a serologic assay to test for viral
contamination including murine norovirus, mouse rotavirus,
and mouse cytomegalovirus; PCR (both 16S and pathogen-
specific), microscopy, and culturing to test for bacteria; and
gross examination of animals to test for parasites (Charles
River Germ-Free Mouse Report). Additionally, any unique
mouse strain to be studied under germ-free conditions must be
rederived in these facilities, and this limits the number of different
genotypes that are feasible to study. Further, maintenance of mice
in isolators may make it impractical or challenging to conduct
some studies (for example, behavioral testing or pathogen
infections).
An alternate method that has emerged to avoid some of
these complications has been the use of antibiotics treatment
(Figure 1). Treatment with broad-spectrum antibiotics is
commonly used to deplete the gut microbiota of mice, and
can be readily applied to any genotype or condition of mouse.
Unlike germ-free conditions, under which complete sterility
is maintained throughout life, antibiotics can deplete bacterial
populations in mice which were normally colonized since birth.
Germ-free animals are broadly impaired in many aspects of
development and early immune education, whereas antibiotics
treatment in adult mice specifically allows for study of the
role of bacteria in maintaining cell functionality and signaling
pathways after development. Alternatively, some studies deliver
antibiotics in drinking water to pregnant dams to limit maternal
transfer of microbes and then maintain the cage on the regimen
during weaning to study the effects of bacterial depletion early
in development (Lamousé-Smith et al., 2011; Deshmukh et al.,
2014; Gonzalez-Perez et al., 2016; Li et al., 2017).
Due to differences in mechanism of action, antibiotics can
selectively deplete different members of the microbiota. For
example, metronidazole and clindamycin both target anaerobes,
vancomycin is only effective against gram-positive bacteria, and
polymyxin B specifically targets gram-negative bacteria (Atarashi
et al., 2011; Schubert et al., 2015). Individual antibiotics can be
used to shift the composition of the gut microbiota in order
to identify classes of bacteria relevant to different phenotypes
(Schubert et al., 2015; Zackular et al., 2016). In contrast, a cocktail
of different classes of antibiotics can be used to broadly deplete
the gut microbiota. Researchers have used various regimens
which differ in antibiotic combination, dose, and length of
treatment (Table 1). All of these combinations broadly target
Gram-positive, Gram-negative, and anaerobic bacteria. Often,
antibiotics are diluted in drinking water and mice are allowed to
drink ad libitum throughout the course of treatment; therefore,
actual delivered doses can vary. Some protocols additionally
include antifungals in the cocktail to avoid fungal overgrowth
during treatment (Reikvam et al., 2011; Grasa et al., 2015;
Zákostelská et al., 2016). Many also add sweeteners such as sugar,
Splenda, or Kool-aid to mask any bitterness and ensure mice
drink the antibiotics-containing water (Abt et al., 2012; Baldridge
et al., 2015; Emal et al., 2017). However, there are reports of
mice avoiding water and becoming dehydrated when provided
antibiotics in this manner (Hill et al., 2010; Reikvam et al.,
2011; Zákostelská et al., 2016). Daily oral gavage can prevent
dehydration and allow delivery of a precise dose of antibiotics,
so this method is sometimes used alone or in combination with
delivery in drinking water, though it is more labor-intensive
(Kuss et al., 2011; Reikvam et al., 2011).
Validation of bacterial depletion can be performed with
culture-based methods by assessing the colony-forming units
(CFUs) from fecal samples plated in aerobic and/or anaerobic
conditions on non-selective media. However, this method only
accounts for cultivatable microbes. Quantitative PCR of the gene
encoding 16S rRNA allows for culture-independent assessment
of gastrointestinal bacterial load. Broad-spectrum antibiotics
treatment can decrease bacterial load by multiple orders of
magnitude in 2 weeks of treatment or less (Baldridge et al., 2015;
Gonzalez-Perez et al., 2016; Brown et al., 2017). Both germ-
free and antibiotics-treated mice allow for the introduction of
microbes in which the contributions of defined bacterial species
or consortia can be studied (Tan et al., 2016; Staley et al., 2017).
Although some phenotypes seen with antibiotics treatment
are attributed to removal of a single bacterial species, many
differences that occur are due to broad decreases in bacterial
load. Consistent with this, treating bacterially-depleted mice with
conserved pattern recognition receptor ligands such as flagellin
(Ichinohe et al., 2011; Oh et al., 2014) or CpG dinucleotides
(Ichinohe et al., 2011; Hill et al., 2012) can restore some defects,
even in the absence of microbiota restoration.
Although most studies attribute phenotypic differences
after antibiotics treatment to the depletion of gut microbes,
some studies have assessed how regimens affect commensal
populations at other sites. Oral antibiotic regimens can decrease
culturable bacteria in the respiratory tract (Ichinohe et al., 2011;
Abt et al., 2012; Brown et al., 2017) and the vagina of mice
(Oh et al., 2016), but do not affect skin bacterial communities
(Naik et al., 2012). Importantly, though rarely quantified,
antibiotics treatment also likely drastically affects bacteriophage
populations, though there is debate in the literature about
whether phage play important roles in transfer of antibiotic
resistance genes (Modi et al., 2013; Enault et al., 2017; Górska
et al., 2018). Antibiotics treatment can allow for the outgrowth
of commensal fungal species, potentially confounding results as
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FIGURE 1 | Comparison of the advantages and disadvantages of germ-free and antibiotics-treated mouse model systems.
these organisms can alter immune function, hence the inclusion
of antifungals in some antibiotics treatment regimens (Noverr
et al., 2004; Kim et al., 2014). An increasing appreciation for
important roles for the virome and mycobiome may lead to
enhanced interrogation of these effects in the future, as well as the
potential impact of antibiotics on eukaryotic viruses and archaea
(Norman et al., 2014). An important final potential disadvantage
of antibiotics treatment can be the evolution or development
of antibiotic-resistant bacteria and their subsequent selection
and outgrowth in mouse intestines (Zhang et al., 2013; Morgun
et al., 2015). Depending upon the starting bacterial composition,
antibiotic cocktail, duration of treatment, and phenotypic read-
out, antibiotic-resistance may confound findings in experiments,
especially if resistant bacteria are present in only a subset of
tested mice. Longitudinal analysis of bacterial populations in
all experimental groups can aid in detection of resistance and
analysis of whether resistant bacteria may affect experimental
results.
Mice on antibiotics are not completely cleared of bacteria, but
significant reductions in bacterial load are associated with shifts
in cell populations, signaling pathways, and organ morphology,
with results often paralleling what is seen in germ-free mice.
EFFECTS OF THE MICROBIOTA ON CELL
POPULATIONS AND CYTOKINES
Although many aspects of murine physiology are affected
by microbial populations, the effects of antibiotics treatment
on immune cell populations are some of the most well-
studied (Figure 2). The immune system constantly responds
to both pathogenic and commensal microbial populations, and
shifts after antibiotics treatment reflect the dependence of cell
populations and function on bacterial signals. While results of
cell composition analysis are not uniform across studies, we will
describe the most prominent and consistent observations (see
Table 2 for exact findings by different groups).
MYELOID CELLS
Innate immune cells lack antigen-specific receptors, responding
instead to broadly conserved microbial patterns. As innate
cells continuously interface with the microbial populations
constituting the microbiota, sensing of these microbes via pattern
recognition receptors is essential for maintenance of normal host
physiology (Chu and Mazmanian, 2013; Fawkner-Corbett et al.,
2017).
Myeloid cell populations, which include macrophages,
monocytes, and granulocytes, are broadly decreased in systemic
sites after antibiotics treatment, similar to what is seen in
germ-free mice (Khosravi et al., 2014). Although monocytes are
generally not diminished in the bone marrow or peripheral blood
of mice receiving antibiotics (Zhang et al., 2015; Josefsdottir et al.,
2017), these cells have a reduced migratory capacity consistent
with their decreased presence in peripheral tissues (Zhang et al.,
2015; Emal et al., 2017). In contrast, the effects of antibiotics
treatment on inflammatory monocytes and macrophages are
more variable, with some groups reporting decreases in blood,
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TABLE 1 | Broad-spectrum antibiotics treatment regimens.





0.5–1.0 g/L each 10 weeks Atarashi et al., 2008
Ciprofloxacin +
metronidazole
1 g/L each 2 weeks Josefsdottir et al., 2017
Vancomycin + ampicillin +
polymixin
0.1–1.0 g/L each 4 weeks Kim et al., 2017
Vancomycin + neomycin +
metronidazole
0.5–1.0 g/L each 7 days Brandl et al., 2008; Kinnebrew
et al., 2010
2 weeks Kool-Aid Josefsdottir et al., 2017
Streptomycin + colistin +
ampicillin
1–5 g/L each 6 weeks 2.5% sucrose Sawa et al., 2011
Ampicillin + neomycin +
streptomycin + vancomycin
0.5–1.0 g/L each 4–5 weeks Khosravi et al., 2014
Cefoxitin + gentamicin +
metronidazole +
vancomycin
1 g/L 10 days Ganal et al., 2012
Gentamicin + ciprofloxacin
+ streptomycin + bacitracin
0.15–2 g/L each 4 weeks 3% sucrose Yan et al., 2016
Vancomycin + neomycin +
kanamycin + metronidazole
0.5–1.0 g/L each 3 weeks Gury-BenAri et al., 2016
Vancomycin + ampicillin +
kanamycin + metronidazole
0.5–1.0 g/L each Levy et al., 2015
Vancomycin + neomycin +
ampicillin + metronidazole
0.35–1.0 g/L each 7 days 3% sucrose, 1%
glucose, or
Kool-aid
Ochoa-Repáraz et al., 2009
2 weeks Hägerbrand et al., 2015;
Hashiguchi et al., 2015; Knoop
et al., 2015; Brown et al., 2017;
Emal et al., 2017; Josefsdottir
et al., 2017; Steed et al., 2017;
Burrello et al., 2018; Thackray
et al., 2018
3 or more weeks Rakoff-Nahoum et al., 2004;
Ivanov et al., 2008; Vaishnava
et al., 2008; Ichinohe et al.,
2011; Ismail et al., 2011; Yoshiya
et al., 2011; Naik et al., 2012;
Corbitt et al., 2013; Diehl et al.,
2013; Balmer et al., 2014;
Mortha et al., 2014; Oh et al.,
2014; Johansson et al., 2015;
Wu et al., 2015; Zhang et al.,
2015; Park et al., 2016; Yan
et al., 2016; Cervantes-Barragan
et al., 2017; Ge et al., 2017; Li
et al., 2017; Durand et al., 2018
3 4-day treatments
with 3 day rests
Adami et al., 2018
Gavage Vancomycin + neomycin +
ampicillin + metronidazole
+ gentamicin
200 µl of 0.5–1.0 g/L each
by daily gavage
3 day Kelly et al., 2015
10 days Hill et al., 2010
Bacitracin + neomycin +
streptomycin





Frontiers in Physiology | www.frontiersin.org 4 October 2018 | Volume 9 | Article 1534
Kennedy et al. Germ-Free and Antibiotics Treatment Models
TABLE 1 | Continued
Method Antibiotics Concentration Duration Additions References




adjusted pH to 4
Grasa et al., 2015
Combination Ampicillin by drinking water;
vancomycin + neomycin +
metronidazole by gavage
1.0g/L in water
10 ml/kg of 5–10 g/L by
gavage every 12 h
10–21 days Amphotericin B
(anti-fungal)
Reikvam et al., 2011; Hintze
et al., 2014
Vancomycin + neomycin +
ampicillin + metronidazole
10mg each by daily gavage





Kuss et al., 2011
Kanamycin + gentamicin +
colistin + metronidazole +
vancomycin
200 µl of 0.35–4 mg/ml by
daily gavage, and mixed





Bashir et al., 2004; Stefka et al.,
2014




0.3–2mg each by daily
gavage, and 0.25 mg/ml in
water
2 weeks Amphotericin B
(anti-fungal)
Zákostelská et al., 2016
Oral streptomycin +
ampicillin in drinking water
20 mg/mouse orally and 1
g/L in drinking water
1–2 weeks Kim et al., 2018
Streptomycin by gavage,
followed by vancomycin +
neomycin + ampicillin +
metronidazole by drinking
water
100 mg/mouse for single
gavage and





1% sucrose Kernbauer et al., 2014
FIGURE 2 | Selected effects of microbiota depletion on cells in the gastrointestinal tract and spleen. Populations of different cell types are altered in association with
depletion of the microbiota in both the gastrointestinal tract (Left) and the spleen (Right). Both secretory IgA (sIgA) and immune cell types are depleted in the
intestine, while dendritic cells and neutrophils are depleted, but basophils are enriched, in the spleen. Please see Table 2 for more detailed findings by different groups
and in other tissues.
bone marrow, and peripheral tissues (Zhang et al., 2015; Hergott
et al., 2016; Ekmekciu et al., 2017) and others reporting no
significant differences at baseline or after infection (Abt et al.,
2012; Oh et al., 2016; Brown et al., 2017; Robak et al., 2018).
Even when cell numbers are similar, macrophages are often less
mature after antibiotics treatment, impairing their responses to
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TABLE 2 | Effects of the microbiota on cell populations.
Broad-spectrum antibiotics References Germ-Free References
Monocytes ↓ in spleen
similar in blood, BM
↓ inflammatory monocytes in BM, spleen,
blood
Similar inflammatory monocytes in vaginal
mucosa after HSV-2 infection, in lung after
flu infection
Abt et al., 2012; Balmer
et al., 2014; Zhang et al.,
2015; Oh et al., 2016;
Josefsdottir et al., 2017
↓ or similar in blood
↓ in BM, spleen
↓ inflammatory monocytes in
spleen, similar but trend ↓ in BM;
similar in SI, colon
Similar inflammatory monocytes
in mesenteric LN
after S. typhimurium infection
Balmer et al., 2014;
Khosravi et al., 2014;
Fernández-Santoscoy
et al., 2015; Zhang
et al., 2015; Hergott
et al., 2016; Tan et al.,
2016
Increased inflammatory monocyte turnover
and apoptosis in bloodstream; decreased
migratory capacity of BM monocytes
Hergott et al., 2016; Emal
et al., 2017
Macrophages ↓ in SI, colon; ↓ or similar in spleen, liver;
similar in PP, mesenteric LN, cervical LN,
kidney, lungs; ↑ in BM
Similar in lungs after P. aeruginosa or flu
infection
Ochoa-Repáraz et al., 2009;
Abt et al., 2012; Corbitt
et al., 2013; Zhang et al.,
2015; Ekmekciu et al.,
2017; Emal et al., 2017;
Robak et al., 2018
↓ or similar in spleen
↓ in liver
Ganal et al., 2012;
Corbitt et al., 2013;
Khosravi et al., 2014
Less mature in kidney, liver, spleen;
decreased cytokine production in lung
after respiratory infection
Abt et al., 2012; Brown




↓ mDCs, pDCs in spleen; ↓ activated DCs
in SI, colon, mesenteric LN, spleen; ↓
CD103+ DCs in lung; ↓ or similar
CD103+ DCs in mesenteric LN
Similar in lung/mediastinal LN after flu
infection, similar in vaginal mucosa before
or after HSV-2 infection
Abt et al., 2012;
Hägerbrand et al., 2015; Oh
et al., 2016; Ekmekciu et al.,
2017; Thackray et al., 2018
↓ in spleen; ↓ or similar in
mesenteric LN
Similar in skin; similar cDCs in
spleen
Walton et al., 2006;




Similar surface markers in lung, altered in
mesenteric LN, PP
Impaired type 1 IFN production and
priming of CD8T cells after flu infection
Ochoa-Repáraz et al., 2009;
Ichinohe et al., 2011; Abt
et al., 2012; Ganal et al.,
2012; Thackray et al., 2018
Decreased maturity but similar
antigen presentation abilities
impaired type 1 IFN production
Walton et al., 2006;
Ganal et al., 2012
Granulocytes ↓ total in BM; similar in blood Balmer et al., 2014;
Josefsdottir et al., 2017
↓ total in BM; similar in blood Balmer et al., 2014
Neutrophils ↓ in BM, spleen, blood; similar in liver,
BALF, vaginal mucosa;
↑ in lung after P. aeruginosa, flu, S.
pneumoniae or K. pneumoniae infection
Abt et al., 2012; Zhang
et al., 2015; Hergott et al.,
2016; Oh et al., 2016;
Brown et al., 2017; Li et al.,
2017; Robak et al., 2018
↓ or similar in spleen, BM
↓ blood
similar in mesenteric LN after S.
typhimurium infection
↓ in lung after K. pneumoniae
infection
Fagundes et al., 2012;
Khosravi et al., 2014;
Fernández-Santoscoy
et al., 2015; Sturge
et al., 2015; Zhang
et al., 2015; Hergott
et al., 2016;
Josefsdottir et al., 2017
Decreased accumulation in BM or blood
of neonates
Increased turnover and apoptosis in
bloodstream; Fewer aged neutrophils in
blood
Deshmukh et al., 2014;
Zhang et al., 2015; Hergott
et al., 2016
Decreased accumulation in BM
or blood of neonates
Fewer aged neutrophils in blood
Deshmukh et al., 2014;
Zhang et al., 2015
Similar phagocytosis/reactive oxygen
species production, adhesion in neonates;
impaired neutrophil extracellular trap
formation in vitro
Deshmukh et al., 2014;




↑ basophils in blood, spleen
Similar mast cells, eosinophils in blood
↑ eosinophils in inguinal subcutaneous
adipose tissue, vaginal mucosa
Hill et al., 2012;
Suárez-Zamorano et al.,
2015; Oh et al., 2016
↑ basophils in blood, spleen
similar eosinophils and mast cells
in skin
Hill et al., 2012; Naik
et al., 2012
↑ eosinophils in lung/BALF after allergen
exposure
Hill et al., 2012; Adami
et al., 2018
(Continued)
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TABLE 2 | Continued
Broad-spectrum antibiotics References Germ-Free References
Lymphocytes Similar in spleen; ↓ in lung, liver Cheng et al., 2014
αβ T cells ↓ in PP, mesenteric LN, cervical LN, SI,
colon
Similar or ↑ in BM
Similar in blood, liver
↓ or ↑ in spleen
Ochoa-Repáraz et al., 2009;
Zhang et al., 2015;
Ekmekciu et al., 2017;
Josefsdottir et al., 2017; Li
et al., 2017
↓ in SI, blood, spleen
Similar in skin
↑ in BM
Naik et al., 2012;
Kernbauer et al., 2014;
Zhang et al., 2015
CD4T cells ↓ in PP, cervical LN, SI, colon, spleen,
blood
Similar in BM
Similar or ↓ in mesenteric LN, SI
Similar or ↓ or ↑ in spleen
↓ % CD4+ memory cells in SI, colon,
mesenteric LN, spleen
Ivanov et al., 2008;
Ochoa-Repáraz et al., 2009;
Sawa et al., 2011;
Kernbauer et al., 2014;
Ekmekciu et al., 2017;
Josefsdottir et al., 2017;
Burrello et al., 2018;
Thackray et al., 2018
↓ in SI, mesenteric LN, BM
↓ or similar in colon, spleen
Similar, blood, cutaneous LN
Huang et al., 2005;
Mazmanian et al.,
2005; Atarashi et al.,
2008; Sawa et al.,
2011; Naik et al., 2012;
Sjögren et al., 2012;
Smith et al., 2013;
Kernbauer et al., 2014
Impaired activation after HSV-2 infection Oh et al., 2016
Th1 cells (Ifnγ+) ↓ in SI, colon
Similar in mesenteric LN, spleen, vaginal
mucosa or draining LNs, skin
Naik et al., 2012; Kernbauer
et al., 2014; Oh et al., 2016;
Ekmekciu et al., 2017
↓ in SI, mesenteric LN, colon,
skin
Similar or ↓ in mesenteric LN
Similar in cecal patch, colon
↓ in draining lymph nodes after
EAE induction?
Zaph et al., 2008; Lee
et al., 2011; Naik et al.,
2012; Kernbauer et al.,
2014
↓ IFNγ response to flu
Similar IFNγ response to OVA, respiratory
HSV-2, L. pneumophila
↑ IFNγ response to Salmonella in
mesenteric LN, SI
Ichinohe et al., 2011; Diehl
et al., 2013; Kim et al., 2018
Th2 cells (IL4+) ↑ in mediastinal LN after allergen exposure Hill et al., 2012
Th17 cells
(IL17+, Rorc+)
↓ in SI, colon, mesenteric LN, spleen
Similar in skin, liver
Atarashi et al., 2008; Ivanov
et al., 2008; Sawa et al.,
2011; Naik et al., 2012;
Ekmekciu et al., 2017; Li
et al., 2017
↓ in colon, cecum, mesenteric
LN, skin
Similar or ↓ in PP
Similar or ↓ or ↑ in SI
↑ in cecal patch, colon
Atarashi et al., 2008;
Ivanov et al., 2008;
Zaph et al., 2008;
Sawa et al., 2011; Naik
et al., 2012; Kernbauer





Similar or ↓ in SI, spleen, PP
↓ or ↑ in mesenteric LN
Similar in BM, liver
↑ in cervical LN, lung
Ivanov et al., 2008;
Ochoa-Repáraz et al., 2009;
Ichinohe et al., 2011;
Mortha et al., 2014;
Ekmekciu et al., 2017;
Josefsdottir et al., 2017; Li
et al., 2017; Thackray et al.,
2018
↓ in PP, colon
Similar in spleen, mesenteric LN,
peripheral LN, cutaneous LN,
cecal patch, colon, blood,
thymus
↑ in SI, skin; ↑ in draining LN and
spleen after EAE induction
↓ Rorγt+ Tregs in colon, SI,
MLN; similar or ↓ Helios+,
similar Gata3+ Tregs in colon
Ivanov et al., 2008;
Zaph et al., 2008; Lee
et al., 2011; Naik et al.,
2012; Smith et al.,
2013; Ohnmacht et al.,
2015; Durand et al.,
2018
CD8+ T cells ↓ in SI, colon, blood
Similar or ↑ in mesenteric LN
↓ or ↑ in spleen
↑ in PP, cervical LN, BM
Ochoa-Repáraz et al., 2009;
Kernbauer et al., 2014;
Ekmekciu et al., 2017;
Josefsdottir et al., 2017;
Thackray et al., 2018
↓ in mesenteric LN
Similar in SI, colon, blood,
cutaneous LN, spleen
Huang et al., 2005;
Naik et al., 2012;
Kernbauer et al., 2014
Similar IFNγ+ in SI, vaginal mucosa or
draining LNs
Impaired response to flu, vaginal HSV-2;
similar response to OVA, respiratory
HSV-2, L. pneumophila
Kernbauer et al., 2014; Oh
et al., 2016
Ichinohe et al., 2011,?; Abt
et al., 2012; Oh et al., 2016
↓ IFNγ+ in SI, colon, mesenteric
LN
Kernbauer et al., 2014
(Continued)
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TABLE 2 | Continued
Broad-spectrum antibiotics References Germ-Free References
CD4+CD8aa+
cells
↓ in SI epithelium Cervantes-Barragan et al.,
2017
↓ in SI epithelium Cervantes-Barragan
et al., 2017
γδ T cells Similar IL-17+ in SI
↓ IL-17+ in liver
Ivanov et al., 2008; Li et al.,
2017
Similar in skin
Similar or ↑ in SI
↓ IL-17+ in SI, skin, liver
Bandeira et al., 1990;
Ivanov et al., 2008;
Ismail et al., 2011; Naik
et al., 2012; Li et al.,
2017
Less activated and more apoptotic in liver,
↓ production of antimicrobials in SI
Ismail et al., 2011; Li et al.,
2017
↓ production of antimicrobials in
SI, less activated in liver,
diminished response to mucosal
injury in colon
Ismail et al., 2009,
2011; Li et al., 2017
NK T cells Similar or ↓ in spleen
Similar in PP, cervical LN, mesenteric LN,
liver
↑ in colon
Ochoa-Repáraz et al., 2009;
Li et al., 2017; Burrello
et al., 2018
↑ in colon Kernbauer et al., 2014
B cells ↓ in SI, colon, PP
Similar or ↓ in spleen, blood, BM
Similar in mesenteric LN, cervical LN, liver
Ochoa-Repáraz et al., 2009;
Yoshiya et al., 2011; Zhang
et al., 2015; Ekmekciu et al.,
2017; Josefsdottir et al.,
2017; Li et al., 2017;




↓ IgA, IgG production in SI
Kernbauer et al., 2014;
Zhang et al., 2015
Antibodies Similar IgM, IgG in BALF, IgG in serum, ↑
in serum after allergen exposure
↓ IgA in BALF, blood, feces
↑ IgE in serum at baseline, after allergen
exposure
Atarashi et al., 2008; Hill
et al., 2012; Oh et al., 2014;
Stefka et al., 2014;
Uchiyama et al., 2014;
Adami et al., 2018; Lynn
et al., 2018; Robak et al.,
2018
Similar IgG in serum, ↑ after
allergen exposure
↓ IgA in feces
↑ IgE in serum at baseline, after
allergen exposure
Atarashi et al., 2008;
Hill et al., 2012; Oh
et al., 2014; Stefka
et al., 2014
↓ antigen-specific response to vaccines in
neonates, not adults
↓ flu-specific IgG, IgA after infection, IgG
early after flu vaccine
↑ Salmonella-specific IgG in blood and IgA
in feces
↑ rotavirus-specific IgA in serum, feces,
only at later times after infection
Ichinohe et al., 2011;
Lamousé-Smith et al.,
2011; Abt et al., 2012; Diehl
et al., 2013; Oh et al., 2014;
Uchiyama et al., 2014; Li
et al., 2017; Lynn et al.,
2018
↓ Ova-specific IgG in response
to Ova immunization at all ages
tested
↓ flu-specific IgM in serum after
infection, IgG early after flu
vaccine
↑ rotavirus-specific IgA, IgG in
serum, only at later time points
Lamousé-Smith et al.,
2011; Abt et al., 2012;
Oh et al., 2014;
Uchiyama et al., 2014
Innate lymphoid
cells (ILCs)
↓ ILC3s and ILC1s in PP
↑ ILC3s in terminal ileum PP
Similar or ↑ ILC3s in SI LP
↑ ILC2 in vaginal mucosa
↓ GM-CSF+ ILC3s in colon
ILC1 and ILC2 expression becomes more
ILC3-like
Sawa et al., 2011; Mortha
et al., 2014; Hashiguchi
et al., 2015; Gury-BenAri
et al., 2016; Oh et al., 2016;
Kim et al., 2017
↑ ILC2s in SI; similar activation
Similar or ↑ ILC3s in SI
Similar ILC1 in SI
Sawa et al., 2011;
Kernbauer et al., 2014;
Gury-BenAri et al.,





Similar in PP, mesenteric LN, cervical LN,
liver
Ochoa-Repáraz et al., 2009;
Li et al., 2017
Similar in spleen Ganal et al., 2012
Impaired cytotoxicity and cytokine
production in spleen
Ganal et al., 2012 Impaired cytotoxicity and
cytokine production in spleen
Ganal et al., 2012
BALF, bronchoalveolar lavage fluid; BM, bone marrow; EAE, experimental autoimmune encephalomyelitis; LN, lymph node; PP, Peyer’s patch; SI, small intestine.
pathogens (Abt et al., 2012; Brown et al., 2017; Emal et al.,
2017).
Bulk granulocytes decrease in the bone marrow of antibiotics-
treated mice, though their numbers in peripheral blood are
similar (Balmer et al., 2014; Josefsdottir et al., 2017). Neutrophils
decrease in bone marrow and in peripheral sites, with an
increased rate of apoptosis and decrease in aged neutrophils in
the bloodstream after microbiota depletion (Deshmukh et al.,
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2014; Zhang et al., 2015; Hergott et al., 2016). However,
neutrophil populations are not diminished at the site of infection
after pathogen exposure in antibiotics-treated mice (Abt et al.,
2012; Oh et al., 2016; Brown et al., 2017; Robak et al., 2018). In
contrast to neutrophils, the proliferation of basophil precursors
in the bone marrow is increased after antibiotics treatment,
associated with increased basophils in the periphery and an
enhanced response to allergen exposure (Hill et al., 2012).
Similarly, eosinophils in various tissues are enhanced at baseline
(Suárez-Zamorano et al., 2015; Oh et al., 2016), and in the
lung after inhaled allergen exposure (Hill et al., 2012). These
alterations in granulocyte populations are consistent with a shift
from type 1 to type 2 immune responses after depletion of the
commensal microbiota.
Various dendritic cell subsets are also reduced after antibiotics
treatment at both mucosal and systemic sites (Ichinohe et al.,
2011; Ekmekciu et al., 2017; Thackray et al., 2018), although these
differences may not be apparent after infection (Abt et al., 2012;
Oh et al., 2016). Differences in dendritic cell numbers have not
been reported in germ-free mice, though impairment in priming
has been seen (Walton et al., 2006; Ganal et al., 2012).
Reductions in innate immune cell number and function,
characteristic of both germ-free mice and antibiotics-treated
mice, may be explained by diminished cytokine and chemokine
levels, which are necessary for normal cell recruitment,
differentiation, and functionality (Mortha et al., 2014; Brown
et al., 2017). Reductions in myeloid populations are likely
not explained by decreases in progenitor populations: although
antibiotic exposure beginning in utero can reduce postnatal
granulocytosis (Deshmukh et al., 2014), treatment in adult mice
does not reduce myeloid progenitor populations in the bone
marrow (Josefsdottir et al., 2017; Thackray et al., 2018).
LYMPHOID CELLS
In contrast to what is seen with myeloid progenitors, common
lymphoid progenitors are reduced in the bone marrow after
microbiota depletion (Josefsdottir et al., 2017; Thackray et al.,
2018), consistent with what is seen in some, but not all, germ-
free models (Balmer et al., 2014; Iwamura et al., 2017). Total
lymphocytes are similarly reduced in the peripheral blood after
antibiotics treatment (Josefsdottir et al., 2017).
The effects of the microbiota in regulating differentiated T
cell populations has been widely explored, but results found are
somewhat variable. αβ T cells generally decrease in peripheral
organs (Ochoa-Repáraz et al., 2009; Zhang et al., 2015; Ekmekciu
et al., 2017), although not in the bone marrow or blood (Zhang
et al., 2015; Josefsdottir et al., 2017). Similarly, many reports
suggest that CD4+ T helper cells decrease in tissues (Ochoa-
Repáraz et al., 2009; Kernbauer et al., 2014; Ekmekciu et al.,
2017; Josefsdottir et al., 2017; Thackray et al., 2018), as do CD4+
T memory cells (Ekmekciu et al., 2017), although others see
either no difference or increases in specific tissues (Ivanov et al.,
2008; Sawa et al., 2011; Ekmekciu et al., 2017; Josefsdottir et al.,
2017; Burrello et al., 2018). Th1 cells tend to decrease in the
gastrointestinal tract (Naik et al., 2012; Kernbauer et al., 2014;
Ekmekciu et al., 2017), but not in extra-intestinal tissues (Naik
et al., 2012; Oh et al., 2016; Ekmekciu et al., 2017), whereas
Th17 cells decrease in most tissues studied (Atarashi et al., 2008;
Ivanov et al., 2008; Sawa et al., 2011; Naik et al., 2012; Ekmekciu
et al., 2017). The effects of microbial depletion on Th2 cells are
less well-studied, although they have been seen to increase in
lymph nodes after allergen exposure (Hill et al., 2012). Results
with regulatory T cells are inconsistent across studies, with some
citing decreases in different tissues (Ochoa-Repáraz et al., 2009;
Mortha et al., 2014; Ekmekciu et al., 2017; Thackray et al., 2018),
others seeing similar numbers regardless of antibiotics treatment
(Ivanov et al., 2008; Ichinohe et al., 2011; Josefsdottir et al., 2017;
Li et al., 2017), and still others seeing increases in some sites
(Ochoa-Repáraz et al., 2009; Ichinohe et al., 2011).
Similar to CD4+ T cells, cytotoxic CD8+ T cells generally
decrease in the intestine after antibiotics, though results at other
sites are more varied (Ochoa-Repáraz et al., 2009; Kernbauer
et al., 2014; Ekmekciu et al., 2017; Josefsdottir et al., 2017;
Thackray et al., 2018). Proinflammatory cytokine production
from cytotoxic T cells is not diminished at baseline after
antibiotics treatment, but has been reported to decrease in
response to infection with some pathogens (Ichinohe et al., 2011;
Abt et al., 2012; Kernbauer et al., 2014; Oh et al., 2016).
Reports of B cell population shifts are varied, with some
groups seeing declines in the blood, bone marrow, and tissues
after antibiotics treatment, and others noting similar numbers
regardless of microbiota depletion (Ochoa-Repáraz et al., 2009;
Yoshiya et al., 2011; Zhang et al., 2015; Ekmekciu et al.,
2017; Josefsdottir et al., 2017; Li et al., 2017; Thackray et al.,
2018). Likewise, shifts in antibody responses are inconsistent—in
general, total IgG and IgM levels remain similar in different sites
analyzed, but secretory and serum IgA levels tend to decrease and
serum IgE levels increase after microbiota depletion (Hill et al.,
2010; Oh et al., 2014; Uchiyama et al., 2014; Adami et al., 2018;
Lynn et al., 2018; Robak et al., 2018). Antigen-specific response
to infection or vaccination vary by pathogen, mouse age, and
time point after exposure analyzed, but neonates in particular
generally produce a less robust response to vaccination after
exposure to antibiotics (Ichinohe et al., 2011; Lamousé-Smith
et al., 2011; Abt et al., 2012; Diehl et al., 2013; Oh et al., 2014;
Uchiyama et al., 2014; Li et al., 2017; Lynn et al., 2018).
Innate-like lymphocytes (including CD8αα+ T cells, γδ T
cells, NK T cells) and innate lymphoid cells (ILCs, including
natural killer cells) localize to barrier sites and are influenced
by the presence of commensal microbes (Constantinides,
2018). Double-positive CD4+CD8αα+ T cells serve regulatory
functions in the small intestinal epithelium and are diminished
in antibiotics-treated mice, associated with a reduction in
the bacterium Lactobacillus reuteri which induces this cell
type (Cervantes-Barragan et al., 2017). γδ T cells are present
in epithelial tissues, mediating tissue repair and monitoring
microbial populations. Although studies in germ-free mice
suggest that the microbiota is dispensable for these cells to home
to the intestine or skin (Bandeira et al., 1990; Ismail et al., 2011;
Naik et al., 2012), both germ-free and antibiotics-treated models
indicate that microbial colonization is necessary for normal
activation and production of antimicrobial compounds by these
Frontiers in Physiology | www.frontiersin.org 9 October 2018 | Volume 9 | Article 1534
Kennedy et al. Germ-Free and Antibiotics Treatment Models
TABLE 3 | Effects of the microbiota on cytokine signaling.
Broad-spectrum antibiotics References Germ-Free References
IL-1 family
cytokines
Similar IL-1β in jejunum, colon, BM,
BALF, liver; similar IL-1α in jejunum,
BALF, liver
↓ pro-IL-1 in lung
↓ IL-1β, IL-1α in vaginal washes after
HSV-2 infection; ↓ IL-1β in BALF after
flu infection
↓ Pro-IL-18 in BALF, ↓ IL-18 in colon
trend ↓ IL-18 in vaginal washes after
HSV-2 infection
↑ IL-33 in vaginal mucosa
Ichinohe et al., 2011; Abt
et al., 2012; Levy et al.,
2015; Suárez-Zamorano
et al., 2015; Oh et al., 2016;
Yan et al., 2016; Li et al.,
2017; Robak et al., 2018
↓ IL-1 in BM
↓ IL-1β in SI, colon, trend ↓
BM
↓ IL-1α in skin
↓ IL-18 in colon
↑ IL-33 in colon, SI
Naik et al., 2012; Shaw
et al., 2012; Sjögren et al.,
2012; Singh et al., 2014;
Levy et al., 2015; Ohnmacht
et al., 2015; Yan et al., 2016
Th1 cytokines Similar IL-2 in liver
↓ IFNγ in SI, in vaginal mucosa after
HSV-2 infection; similar IFNγ in SI,
colon, vaginal mucosa at baseline
↓ or similar TNFα in colon, trend ↓ in
BM, ↓ in lung after flu infection; similar
TNFα in vaginal washes, SI, BALF
↓ IL-12 in spleen after
LCMV-infection; similar IL-12 in colon,
SI, vaginal washes with or without
HSV-2 infection
Hill et al., 2010; Abt et al.,
2012; Suárez-Zamorano
et al., 2015; Oh et al., 2016;
Yan et al., 2016; Ekmekciu
et al., 2017; Li et al., 2017;
Burrello et al., 2018; Robak
et al., 2018
↓ TNFα in colon, BM, WAT;
similar in popliteal LN; ↓ in
lung after K. pneumoniae
infection
↑ IL-12β, similar IL-12α in
colon
↓ IFNγ, TNFα in skin, similar
IFNγ in popliteal LN, spleen
after Leishmania infection
↓ IFNγ in draining LN after
EAE induction
Oliveira et al., 2005; Zaph
et al., 2008; Lee et al.,
2011; Caesar et al., 2012;
Fagundes et al., 2012; Naik
et al., 2012; Sjögren et al.,
2012; Yan et al., 2016
Th2 cytokines ↑ IL-4 in inguinal subcutaneous
adipose tissue, in mediastinal LN after
allergen exposure; similar in SI,
vaginal washes
↑ IL-5 in inguinal subcutaneous
adipose tissue, vaginal mucosa;
similar in SI
Similar IL-6 in SI, BM, vaginal
washes, BALF, liver; ↑ in BALF after P.
aerigunosa infection; similar or ↓ in
colon; ↓ in BALF after flu infection, in
spleen after LCMV infection
Similar IL-10 in spleen, lung; similar or
↓ in SI; ↓ in colon
Similar IL-13 in SI; ↑ in inguinal
subcutaneous adipose tissue, in
mediastinal LN after allergen
exposure
Rakoff-Nahoum et al., 2004;
Abt et al., 2012; Hill et al.,
2012; Suárez-Zamorano
et al., 2015; Oh et al., 2016;
Yan et al., 2016; Ekmekciu
et al., 2017; Li et al., 2017;
Burrello et al., 2018; Robak
et al., 2018
Similar IL-6 in colon; similar
or ↑ in BM; similar or ↓ in SI
Similar IL-10 in colon; ↓
IL-10 in WAT
Similar IL-13 in colon
↑ IL-10 in lung after
K. pneumoniae infection
Similar IL-4 in popliteal LN,
spleen after Leishmania
infection
Oliveira et al., 2005; Zaph
et al., 2008; Caesar et al.,
2012; Fagundes et al.,
2012; Shaw et al., 2012;
Sjögren et al., 2012;
Ohnmacht et al., 2015; Yan
et al., 2016
Th17 cytokines ↓ IL-22 in SI, colon
Similar IL-17 in lung; similar or ↓ in SI,
colon; ↓ in liver; ↓ in lung after
S. pneumoniae or K. pneumoniae
infection
Hill et al., 2010; Deshmukh
et al., 2014;
Suárez-Zamorano et al.,
2015; Brown et al., 2017;
Ekmekciu et al., 2017; Li
et al., 2017; Burrello et al.,
2018
↓ IL-17 in SI; ↑ IL-17 in
colon
↓ IL-17 in draining LN after
EAE induction
Ivanov et al., 2008; Zaph
et al., 2008; Deshmukh
et al., 2014
BALF, bronchoalveolar lavage fluid; BM, bone marrow; EAE, experimental autoimmune encephalomyelitis; LN, lymph node; SI, small intestine; WAT, white adipose tissue.
cells (Ivanov et al., 2008; Ismail et al., 2009, 2011; Naik et al.,
2012; Li et al., 2017). Levels of NK T cells are generally similarly
maintained in tissues after antibiotics treatment, though their
activation has not been well-studied (Ochoa-Repáraz et al., 2009;
Li et al., 2017; Burrello et al., 2018). Likewise, ILCs have not
been extensively evaluated after antibiotics treatment, although
multiple studies report shifts in the representation or function
of ILC subsets at mucosal surfaces (Ochoa-Repáraz et al., 2009;
Sawa et al., 2011; Ganal et al., 2012; Mortha et al., 2014;
Hashiguchi et al., 2015; Gury-BenAri et al., 2016; Oh et al., 2016;
Kim et al., 2017; Li et al., 2017).
CYTOKINES
Although shifts in cytokine levels after antibiotics treatment are
variable (Table 3), most studies that report differences describe
a shift away from proinflammatory cytokines. Many associate
microbiota depletion with decreases in the production of IL-1
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family cytokines, Th1 cytokines such as IFNγ and TNFα, and IL-
17 family cytokines. The production of these cytokines is often
similar or reduced specifically in the gastrointestinal tract in naïve
animals, but the diminished response becomes apparent after
challenge with a pathogen, often at the site of infection. For
example, although IL-1 family cytokine levels are similar, pro-
IL-1 and pro-IL-18 are reduced in the vaginal mucosa and lung
in antibiotics-treated mice at baseline, associated with a reduced
production of IL-1 family cytokines in response to infection at
each site (Ichinohe et al., 2011; Abt et al., 2012; Oh et al., 2016;
Robak et al., 2018). Similarly, type 1 cytokines such as IFNγ
and TNFα are generally present at similar levels in tissues after
antibiotics treatment in uninfected mice but reduced at the site of
infection in microbiota-depleted mice (Abt et al., 2012; Oh et al.,
2016; Robak et al., 2018). Inflammatory Th17 cytokines such as
IL-17 and IL-22 are generally reduced in the intestines even at
baseline in antibiotics-treated mice (Hill et al., 2010; Deshmukh
et al., 2014; Ekmekciu et al., 2017), whereas differences in tissues
such as the lung become apparent after infection at that site
(Deshmukh et al., 2014; Suárez-Zamorano et al., 2015). In parallel
with this decrease in inflammatory cytokines, some reports
suggest that there is an increase in the expression of Th2 family
cytokines such as IL-4, IL-5, and IL-13, especially after allergen
exposure, consistent with a shift from Th1 to Th2-type immunity
after microbiota depletion (Hill et al., 2010; Suárez-Zamorano
et al., 2015; Oh et al., 2016).
Broadly, there is reasonable concordance between germ-free
and antibiotics treatment mouse models in alterations of cellular
compartments and cytokines. However, different groups have
reported disparate findings with different antibiotics treatment
regimens, making it challenging to definitively categorize
microbiota-mediated modulatory effects. We propose that
distinct starting microbiota composition and distinct regimens
likely underlie this variability, and highlight this as an area of
much-needed standardization.
MICROBIOTA EFFECTS AT THE ORGAN
LEVEL
In addition to shifts in cell populations and signaling pathways,
antibiotics treatment has been seen to affect organ morphology
more broadly, both in the gastrointestinal tract as well as in
extra-intestinal organs (Table 4). As the bulk of commensals
reside in the gastrointestinal tract where they assist with digestion
and interact closely with epithelial cells, it is not surprising
that many changes are seen in intestinal physiology after
microbial depletion. The length of the whole intestine or the
colon is not affected, but the cecum becomes dramatically
larger, transit time increases, and fecal pellet frequency and
consistency can be altered (Grasa et al., 2015; Suárez-Zamorano
et al., 2015; Ge et al., 2017). Moreover, villi become narrower
(Kernbauer et al., 2014), cellular proliferation decreases (Reikvam
et al., 2011; Ekmekciu et al., 2017), and features such as
tuft cells (Wilen et al., 2018) or goblet-cell antigen passages
(Knoop et al., 2015) are affected in specific regions of the
gastrointestinal tract. Immune function in the intestines is
also affected, as the production of antimicrobial peptides is
reduced (Brandl et al., 2008; Vaishnava et al., 2008; Kinnebrew
et al., 2010; Reikvam et al., 2011), Paneth cells granules are
diminished (Kernbauer et al., 2014), Peyer’s patches become
less abundant and decrease in cellularity (Reikvam et al., 2011;
Grasa et al., 2015; Hashiguchi et al., 2015), expression of Toll-
like receptors is altered (Grasa et al., 2015), and tolerance to
the commensal intestinal microbiota is impaired (Kim et al.,
2018).
Non-gastrointestinal organs also depend on ongoing bacterial
signals to maintain normal morphology. The spleen (Ochoa-
Repáraz et al., 2009; Reikvam et al., 2011; Yoshiya et al., 2011;
Zhang et al., 2015; Josefsdottir et al., 2017; Thackray et al.,
2018), thymus (Josefsdottir et al., 2017), and lymph nodes
(Ichinohe et al., 2011; Durand et al., 2018) may decrease in size
and/or cellularity after antibiotics treatment. Liver regeneration
is impaired in antibiotics-treated mice (Wu et al., 2015) and
bile acid synthesis is altered (Sayin et al., 2013; Zhang et al.,
2014). Additionally, fat pads diminish and bone mass increases,
consistent with a role for the microbiota in maintaining normal
body composition (Suárez-Zamorano et al., 2015; Yan et al.,
2016). There have been a number of intriguing studies recently
exploring the role of the microbiota in regulating brain function
and behavior via the gut-brain axis; this complex topic has been
recently reviewed elsewhere (Cryan and Dinan, 2012; Liu and
Zhu, 2018).
MICROBIOTA REGULATION OF IMMUNE
CHALLENGES
As might be expected, given the systemic and tissue-specific
differences in immune function, antibiotics-treated mice are
more susceptible to a variety of pathogens. For example,
microbiota-depleted mice are more susceptible to bacterial
pathogens such as vancomycin-resistant enterococcus,
Salmonella, and Clostridium difficile in the gastrointestinal
tract (Kinnebrew et al., 2010; Fernández-Santoscoy et al., 2015;
Theriot et al., 2016), a variety of pneumonia-causing bacteria in
the respiratory tract (Brown et al., 2017; Robak et al., 2018), and
systemic Escherichia coli (Deshmukh et al., 2014). Additionally,
after antibiotics treatment, mice are impaired in their response
to vaginal HSV-2 (Oh et al., 2016), flaviviruses (Thackray et al.,
2018), influenza (Ichinohe et al., 2011; Abt et al., 2012), and
cutaneous Leishmania (Naik et al., 2012). However, microbiota-
depleted mice actually become less susceptible to enteric viral
pathogens including murine norovirus and poliovirus (Kuss
et al., 2011; Uchiyama et al., 2014; Baldridge et al., 2015), possibly
due to direct interactions between viral pathogens and enteric
bacteria or due to loss of specific cell types required for viral
infection. Antibiotics-treated mice are additionally impaired in
their development of tolerance to food antigens (Bashir et al.,
2004; Kim et al., 2018) and are more prone to allergic diseases
(Hill et al., 2012; Adami et al., 2018).
Many of the effects after antibiotics treatment in mice are
consistent with what is seen in germ-free models, suggesting
that these are dependent on regular signals from the microbiota.
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TABLE 4 | Effects of the microbiota on individual organs.
Broad-spectrum antibiotics References Germ-Free References
Whole intestine Similar length, ↑ transit time Grasa et al., 2015; Ge et al., 2017
Small intestine ↓ transit time
similar apoptotic cells, fewer
proliferating cells
↓ RegIIIγ and RegIIIβ production
↓ number of PP; ↓ cells in PP
↓ villus width, ↓ T cells/vilus
↓ granules/Paneth cell
altered expression of TLRs
similar tuft cells
Brandl et al., 2008; Vaishnava et al.,
2008; Kinnebrew et al., 2010;
Reikvam et al., 2011; Wichmann
et al., 2013; Kernbauer et al., 2014;
Grasa et al., 2015; Hashiguchi et al.,
2015; Park et al., 2016; Ekmekciu
et al., 2017; Durand et al., 2018;




↓ RegIIIγ, RegIIIβ production
↓ villus width, ↓ T cells/vilus, ↓
cells in LP
↓ cells in PP
↓ mucus thickness, attachment
to epithelium; mucus more
attached




Vaishnava et al., 2008;
Sayin et al., 2013;
Wichmann et al., 2013;
Kernbauer et al., 2014;
Schütte et al., 2014;
Johansson et al., 2015;
Park et al., 2016;
Durand et al., 2018;
Schneider et al., 2018
Cecum ↑ size
↑ villus length and width
↓ SCFAs
decreased thickness of muscularis
propria
Hill et al., 2010; Corbitt et al., 2013;
Kelly et al., 2015; Park et al., 2016;
Yan et al., 2016
↑ size
↑ villus length and width
↓ SCFAs, bile acids
Decreased thickness of
muscularis propria
Hill et al., 2010; Corbitt
et al., 2013; Sayin
et al., 2013; Smith
et al., 2013; Yan et al.,
2016
Colon Similar length, ↑ transit time
↓ RegIIIγ and RegIIIβ, other
anti-microbial factors
↓ epithelial regeneration, ↓
proliferating cells
Similar mucus penetrability
Altered expression of TLRs
↓ tuft cells
↓ SCFAs
Formation of goblet-cell antigen
passages
Reikvam et al., 2011; Wichmann
et al., 2013; Grasa et al., 2015;
Johansson et al., 2015; Knoop et al.,
2015; Ekmekciu et al., 2017; Ge
et al., 2017; Wilen et al., 2018







↓ SCFAs, bile acids
Formation of goblet-cell antigen
passages
He et al., 2003;
Matsumoto et al.,
2012; Sayin et al.,
2013; Wichmann et al.,
2013; Kernbauer et al.,
2014; Johansson et al.,
2015; Knoop et al.,
2015; Levy et al., 2015;
McKinley et al., 2017
Lymph nodes Similar or ↓ cellularity
↓ size and cellularity after flu infection
Ichinohe et al., 2011; Durand et al.,
2018
↓ or similar cellularity
Altered structure
Bauer et al., 1963;
Manolios et al., 1988;
Kernbauer et al., 2014;
Zhang et al., 2015;
Durand et al., 2018
Spleen Similar or ↓ weight
↓ cellularity, fewer leukocytes
Ochoa-Repáraz et al., 2009; Reikvam
et al., 2011; Yoshiya et al., 2011;
Grasa et al., 2015; Suárez-Zamorano
et al., 2015; Zhang et al., 2015;





Bauer et al., 1963;
Mazmanian et al.,
2005; Zhang et al.,
2015
Thymus ↓ weight Josefsdottir et al., 2017 Similar cellularity Nakajima et al., 2014
Liver Similar or ↓ weight
Impaired regeneration
Altered bile acid production
Corbitt et al., 2013; Sayin et al., 2013;
Zhang et al., 2014; Wu et al., 2015;
Yan et al., 2016
Similar weight
Impaired regeneration
Altered bile acid production
Cornell et al., 1990;
Corbitt et al., 2013;
Sayin et al., 2013; Yan
et al., 2016
Fat ↓ weight of abdominal fat pads
↓ inguinal and perigonadal adipose
tissue
Suárez-Zamorano et al., 2015; Yan
et al., 2016
↓ weight of abdominal fat pads
↓ % body fat
Caesar et al., 2012;
Yan et al., 2016
Bone ↑ bone mass Yan et al., 2016 ↑ bone mass vs. short-term SPF
colonized, ↓ bone mass/length
vs. long-term SPF colonized
↑ bone mass vs. conventional
Sjögren et al., 2012;
Yan et al., 2016
PP, Peyer’s patch; TLR, Toll-like receptor; LP, lamina propria; SCFA, short-chain fatty acid; SPF, specific-pathogen-free.
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However, it is important to note that antibiotics can have effects
on eukaryotes independently of the microbiota, as treatment
of germ-free mice with antibiotics can replicate some findings
seen when treating normally colonized mice (Han et al., 2015;
Gopinath et al., 2018). Replicating key findings in germ-free
mice can help confirm that the differences seen after antibiotics
treatment are indeed caused by microbial depletion.
CONSIDERATIONS FOR THE FUTURE
While antibiotics treatment offers an inexpensive and accessible
alternative to germ-free models, results obtained using these
regimens come with the caveats of potential off-target drug
effects and incomplete or inconsistent ablation of microbes.
Additionally, because so many groups use distinct treatment
regimens and mouse microbial populations may be institution-
specific, antibiotics studies are much more challenging to
compare than germ-free mouse studies.
We suggest that some standardization of antibiotics treatment
regimens would be helpful; for example, if a standard cocktail
were employed to demonstrate an initial finding, this could
be compared to other studies, and subsequent follow-up
experiments could be done with modified cocktails as necessary.
Additionally, we suggest that at least a limited assessment of the
replicability of findings in antibiotics-treated mice and germ-
free mice would be of high value for most studies, to rule in or
out potential off-target drug effects or developmental differences
between germ-free and standard pathogen-free mice that may
be important for a phenotype. Finally, it will be critical for
investigators to ensure that microbial loads are consistently
monitored in both antibiotics treatment and germ-free models
to identify any effects of contaminants or antibiotic-resistant
microbes.
Ensuring that we are able to interpret the contribution of
an individual study to the field of microbiota research will
require careful planning and execution of these experiments
on the part of investigators. As we continue to uncover
additional health and disease states in which the microbiota
plays a role, the use of these models will become increasingly
common.
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